InvestorsHub Logo
Followers 74
Posts 3603
Boards Moderated 0
Alias Born 03/23/2013

Re: ORBAPU post# 406287

Monday, 03/27/2023 2:25:05 PM

Monday, March 27, 2023 2:25:05 PM

Post# of 426024
Agree, but unfortunately much of that demand will come from OTC "fish oil". They'll make a killing.

Amarin has done a horrible job at making the health benefits/risks (between the two meds) broadly known.
I predict that if BRAVE shows efficacy, all the DHA laden drugs will be resurrected and once again compete with V. Though DHA has a harmful effect on the cardiovascular system, it has a beneficial effect on the brain - and the public will be led to only care about that.

Amarin needs to be sold prior to BRAVE results to stave off the hyenas (generics, lovaza, OTC) and capitalize on this potential indication.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News